Skip to main content

Eupenta

Product overview

Type
Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b
Commercial Name
Eupenta
Manufacturer
LG Chem Ltd
Responsible NRA
Ministry of Food and Drug Safety
Country
Republic of Korea

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
Carton of 10 vials (100 doses). [Dimensions: 11.6 x 4.8 x 5.5 cm]
Tertiary Packaging
Box of 139 cartons of 10 vials (13900 doses) [Dimensions: 76.4 x 59.0 x 51.5 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.01%
Cold Chain Volume
3.06 cm3/dose (in secondary packaging)

Attachments

Container Photo
Package Insert